GSK Stock Jumps on Long-Term Outlook Boost, $2.5B Share Buyback Plan
GSK Plc's U.S.-listed shares surged Wednesday after the pharmaceutical firm boosted its long-term outlook and launched a $2.5 billion stock buyback on the back of optimism about sales of its new drugs ...
pharmaphorum4d
Five lessons from GSK in social media
The theme of International Women's Day was "inspiring change" and GSK's take on that was to profile inspiring change in the workplace, with content published on the company's website shared via a ...
Blue Trust Inc. Has $423,000 Position in GSK plc (NYSE:GSK)
Blue Trust Inc. lifted its position in GSK plc (NYSE:GSK – Free Report) by 16.7% in the 4th quarter, HoldingsChannel reports. The institutional investor owned 12,505 shares of the pharmaceutical ...
Geneos Wealth Management Inc. Makes New Investment in GSK plc (NYSE:GSK)
Geneos Wealth Management Inc. purchased a new stake in shares of GSK plc (NYSE:GSK – Free Report) during the fourth quarter, ...
GlobalData on MSN4mon
GSK reports positive interim data from mRNA influenza vaccine trial
GSK has reported positive interim results ... responses while maintaining a favourable safety profile. Following these ...
GlobalData on MSN8d
GSK and University of Oxford partner for cancer vaccine research
GSK and the University of Oxford have entered a new research partnership to launch an immuno-prevention programme.
Yahoo Finance24d
GSK Enters Agreement to Acquire IDRx, Inc.
This breadth of mutational coverage, in addition to high selectivity which could improve tolerability, provides potential for a best-in-class profile. Luke Miels, Chief Commercial Officer ...